Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma
A new study led by researchers at the Centro Oncológico Johns Hopkins Kimmel found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of treatment.